UNIVEC, Inc. (OTCMKTS:UNVC)
UNIVEC, Inc. (OTCMKTS:UNVC) stock was a big mover after the specialty pharmaceutical company announced the signing a strategic partnership with AGRiMED. The stock was up by 78% in Tuesday’s trading session, on massive volumes, to end the day $0.00170 a share.
UNVC Stock Performance
The rally came as a surprise as UNIVEC, Inc. (OTCMKTS:UNVC) has been dead silent both in the market and in the news media. The breathtaking rally came as investors reacted to the company’s push to expand its footprint into the fast-growing the legal cannabis business.
Under the terms of the agreement, UNIVEC, Inc. (OTCMKTS:UNVC) is to help AGRiMED on the manufacture and distribution of its medical cannabis transdermal patch for the treatment and relief of approved medical conditions.
“Combining Univec’s medical and pharmaceutical expertise with AGRiMED Industries’ innovative approach to the cannabis marketplace and commitment to its patient-focused services makes a very powerful partnership to expand the treatment options available to the medical community, “said Univec CEO, David Dalton.
According to AGRiMED CEO, Sterling Crockett, the partnership underscores their commitment to providing those in need with therapeutic innovations.
AGRiMED is a limited liability company based in Delaware with operations in the legal cannabis industry. The company’s subsidiaries are in the business of developing, producing, and selling products derived from cannabis across the United States.
Univec Corporate Highlight
UNIVEC, Inc. (OTCMKTS:UNVC) is an integrated licensing manufacturing and marketing company. The firm operates under two divisions dedicated to providing safer healthcare products globally.
The company’s Syringe division develops, licenses, and markets auto-disable and safety syringes worldwide. The Pharmaceutical services division, on the other hand, assists pharmaceutical companies with the marketing and tracking of drug samples via an online system.
UNIVEC, Inc. (OTCMKTS:UNVC) also manufactures and markets sliding sheath syringes designed to protect patients and caregivers from needle stick injuries. The company last reported financial results for the fiscal year ending December 31, 2006. For the period, the company reported a net loss of (-$1.18) million compared to a net loss of (-$1.8) million reported the prior year.
I have no positions in any of the stocks mentioned, and have no plans to initiate any positions within the next 72 hours. All information, including any data, is provided without any guarantees of accuracy.
Don’t miss out! Stay informed on $UNVC and receive breaking news on other hot stocks by signing up for our free newsletter!